Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-02-22 Sale |
2022-02-23 7:07 pm |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
11,139 | $55.29 | $615,827 | 56,478 (Direct) |
View |
| 2022-02-22 Sale |
2022-02-23 7:05 pm |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
11,139 | $55.4 | $617,100 | 11,139 (Direct) |
View |
| 2022-02-22 Sale |
2022-02-23 7:02 pm |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
10,443 | $55.4 | $578,506 | 10,443 (Direct) |
View |
| 2022-02-22 Sale |
2022-02-23 7:00 pm |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
27,847 | $55.39 | $1,542,413 | 1,122,315 (Direct) |
View |
| 2022-01-18 Sale |
2022-01-20 4:07 pm |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer |
6,223 | $42.03 | $261,553 | 23,104 (Direct) |
View |
| 2022-01-10 Sale |
2022-01-11 8:08 pm |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer |
6,870 | $40.76 | $280,020 | 29,327 (Direct) |
View |
| 2022-01-10 Sale |
2022-01-11 8:06 pm |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
20,948 | $40.78 | $854,255 | 45,339 (Direct) |
View |
| 2022-01-10 Sale |
2022-01-11 8:04 pm |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
19,639 | $40.77 | $800,774 | 0 (Direct) |
View |
| 2022-01-10 Sale |
2022-01-11 8:02 pm |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
19,639 | $40.76 | $800,420 | 0 (Direct) |
View |
| 2022-01-10 Sale |
2022-01-11 8:00 pm |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
41,896 | $40.78 | $1,708,429 | 1,094,467 (Direct) |
View |
| 2021-12-21 Sale |
2021-12-23 7:02 pm |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
176,863 | $47.56 | $8,412,278 | 0 (Direct) |
View |
| 2021-12-21 Sale |
2021-12-23 7:00 pm |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
175,000 | $47.59 | $8,328,664 | 10,837 (Direct) |
View |
| 2021-10-18 Sale |
2021-10-19 4:26 pm |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
13,448 | $40.86 | $549,551 | 45,339 (Direct) |
View |
| 2021-10-14 Sale |
2021-10-18 6:00 pm |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
50,000 | $40 | $2,000,000 | 1,133,392 (Direct) |
View |
| 2021-06-14 Sale |
2021-06-15 5:02 pm |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
18,289 | $42.27 | $773,076 | 1,253,903 (Indirect Direct) |
View |
| 2021-05-27 Sale |
2021-05-28 6:00 pm |
Intra-Cellular Therapies Inc. | ITCI | Alafi Christopher D Director |
47,325 | $40.1 | $1,897,746 | 5,689,318 (Indirect Direct) |
View |
| 2021-05-21 Sale |
2021-05-25 6:02 pm |
Intra-Cellular Therapies Inc. | ITCI | Alafi Christopher D Director |
27,675 | $40.45 | $1,119,490 | 5,736,643 (Indirect Direct) |
View |
| 2021-03-02 Sale |
2021-03-04 5:43 pm |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
15,250 | $34.93 | $532,683 | 1,263,425 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-18 Exercise |
2022-02-23 7:07 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
11,139 | $0 | 56,478 (Direct) |
View |
| 2022-02-18 Exercise |
2022-02-23 7:05 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
11,139 | $0 | 11,139 (Direct) |
View |
| 2022-02-18 Exercise |
2022-02-23 7:02 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
10,443 | $0 | 10,443 (Direct) |
View |
| 2022-02-18 Exercise |
2022-02-23 7:00 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
27,847 | $0 | 1,122,315 (Direct) |
View |
| 2022-01-08 Exercise |
2022-01-11 8:08 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer |
13,093 | $0 | 29,327 (Direct) |
View |
| 2022-01-08 Exercise |
2022-01-11 8:06 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
20,948 | $0 | 45,339 (Direct) |
View |
| 2022-01-08 Exercise |
2022-01-11 8:04 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
19,639 | $0 | 0 (Direct) |
View |
| 2022-01-08 Exercise |
2022-01-11 8:02 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
19,639 | $0 | 0 (Direct) |
View |
| 2022-01-08 Exercise |
2022-01-11 8:00 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
41,896 | $0 | 1,094,467 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-04 9:52 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
148 | $52.34 | 8,809 (Direct) |
View |
| 2021-12-31 Option Award |
2022-01-04 9:50 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
300 | $52.34 | 303,485 (Direct) |
View |
| 2021-12-21 Exercise |
2021-12-23 7:02 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
25,000 | $13.86 | 0 (Direct) |
View |
| 2021-12-21 Exercise |
2021-12-23 7:02 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
88,146 | $17.57 | 0 (Direct) |
View |
| 2021-12-21 Exercise |
2021-12-23 7:02 pm |
N/A 2024-07-29 |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
176,863 | $0 | 0 (Direct) |
View |
| 2021-12-21 Exercise |
2021-12-23 7:02 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Halstead Michael EVP and General Counsel |
63,717 | $15.73 | 0 (Direct) |
View |
| 2021-12-21 Exercise |
2021-12-23 7:00 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
72,120 | $17.57 | 10,837 (Direct) |
View |
| 2021-12-21 Exercise |
2021-12-23 7:00 pm |
N/A 2024-06-30 |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
175,000 | $0 | 10,837 (Direct) |
View |
| 2021-12-21 Exercise |
2021-12-23 7:00 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
52,880 | $15.73 | 10,837 (Direct) |
View |
| 2021-12-21 Exercise |
2021-12-23 7:00 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. SVP of Finance CFO |
50,000 | $16.86 | 10,837 (Direct) |
View |
| 2021-10-15 Exercise |
2021-10-19 4:26 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP, Chief Commercial Officer |
13,448 | $0 | 45,339 (Direct) |
View |
| 2021-10-15 Exercise |
2021-10-18 6:00 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
1,075 | $2.84 | 1,133,392 (Direct) |
View |
| 2021-10-15 Exercise |
2021-10-18 6:00 pm |
N/A 2022-04-30 |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
1,075 | $0 | 1,133,392 (Direct) |
View |
| 2021-09-30 Option Award |
2021-10-04 5:43 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | LERNER RICHARD A Director |
402 | $37.28 | 108,093 (Indirect) |
View |
| 2021-09-30 Option Award |
2021-10-04 4:24 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
422 | $37.28 | 303,185 (Direct) |
View |
| 2021-09-30 Option Award |
2021-10-04 4:23 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
215 | $37.28 | 8,661 (Direct) |
View |
| 2021-08-23 Exercise |
2021-08-24 4:06 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
10,000 | $2.84 | 1,183,392 (Direct) |
View |
| 2021-08-23 Exercise |
2021-08-24 4:06 pm |
N/A 2022-04-30 |
Intra-Cellular Therapies Inc. | ITCI | Mates Sharon Chairman, President & CEO |
10,000 | $0 | 1,183,392 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-02 4:55 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
173 | $40.82 | 8,446 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-02 4:52 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
385 | $40.82 | 302,763 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-02 4:47 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | LERNER RICHARD A Director |
367 | $40.82 | 107,691 (Indirect) |
View |
| 2021-06-21 Option Award |
2021-06-22 4:34 pm |
2022-06-21 2031-06-20 |
Intra-Cellular Therapies Inc. | ITCI | Rawlins Michael Director |
40,000 | $0 | 40,000 (Direct) |
View |
| 2021-06-21 Option Award |
2021-06-22 4:26 pm |
2022-06-21 2031-06-20 |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-06-21 Option Award |
2021-06-22 4:23 pm |
2022-06-21 2031-06-20 |
Intra-Cellular Therapies Inc. | ITCI | LERNER RICHARD A Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-06-21 Option Award |
2021-06-22 4:21 pm |
2022-06-21 2031-06-20 |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-06-21 Option Award |
2021-06-22 4:19 pm |
2022-06-21 2031-06-20 |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-06-14 Exercise |
2021-06-15 5:02 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
20,000 | $38.35 | 1,253,903 (Indirect) |
View |
| 2021-06-14 Exercise |
2021-06-15 5:02 pm |
N/A 2026-06-14 |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
20,000 | $0 | 1,253,903 (Indirect) |
View |
| 2021-05-27 Exercise |
2021-06-04 4:05 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
13,767 | $0 | 302,378 (Direct) |
View |
| 2021-05-27 Exercise |
2021-06-04 4:02 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
13,767 | $0 | 1,252,192 (Direct) |
View |
| 2021-04-12 Gift |
2021-04-14 4:05 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
25,000 | $0 | 1,238,425 (Indirect) |
View |
| 2021-03-31 Option Award |
2021-04-02 5:31 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | LERNER RICHARD A Director |
442 | $33.93 | 107,324 (Indirect) |
View |
| 2021-03-31 Option Award |
2021-04-02 5:29 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director |
464 | $33.93 | 288,611 (Direct) |
View |
| 2021-03-31 Option Award |
2021-04-02 5:27 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | Alafi Christopher D Director |
464 | $33.93 | 5,764,318 (Direct) |
View |
| 2021-03-31 Option Award |
2021-04-02 5:26 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director |
208 | $33.93 | 8,273 (Direct) |
View |
| 2021-03-02 Exercise |
2021-03-04 5:43 pm |
N/A N/A |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
20,000 | $26.58 | 1,263,425 (Indirect) |
View |
| 2021-03-02 Exercise |
2021-03-04 5:43 pm |
N/A 2025-06-16 |
Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director |
20,000 | $0 | 1,263,425 (Indirect) |
View |